On-line haemodiafiltration. Safety and efficacy in long-term clinical practice (original) (raw)

AI-generated Abstract

On-line haemodiafiltration (HDF) has emerged as a superior renal replacement therapy for end-stage renal disease (ESRD) patients, integrating diffusive, convective, and adsorptive solute transfer. Initiated in 1984, HDF has shown promising long-term efficacy, contributing significantly to patient survival and maintaining a stable biochemical environment. The study examines the technical aspects, patient demographics, treatment outcomes, and safety profiles of HDF, highlighting its ability to maintain adequate solute clearance while ensuring hemodynamic stability.